{"count": 3, "results": [{"_id": "34777259", "pmid": 34777259, "pmcid": "PMC8578886", "title": "Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study", "journal": "Front Endocrinol (Lausanne)", "authors": ["Vogel F", "Braun L", "Rubinstein G", "Zopp S", "Oßwald A", "Schilbach K", "Schmidmaier R", "Bidlingmaier M", "Reincke M"], "date": "2021-10-27T00:00:00Z", "doi": "10.3389/fendo.2021.765067", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "765067", "score": 50290.305, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Bone Metabolism in Endogenous @<m>DISEASE_Glucocorticoid_Receptor_Deficiency</m> @DISEASE_MESH:C564221 @@@Glucocorticoid Excess@@@: An Exploratory Study", "citations": {"NLM": "Vogel F, Braun L, Rubinstein G, Zopp S, Oßwald A, Schilbach K, Schmidmaier R, Bidlingmaier M, Reincke M. Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study Front Endocrinol (Lausanne). 2021;12():765067. PMID: 34777259", "BibTeX": "@article{34777259, title={Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study}, author={Vogel F and Braun L and Rubinstein G and Zopp S and Oßwald A and Schilbach K and Schmidmaier R and Bidlingmaier M and Reincke M}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={765067}}"}}, {"_id": "35203060", "pmid": 35203060, "pmcid": "PMC8890943", "title": "Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway", "journal": "Korean J Physiol Pharmacol", "authors": ["Tao F", "Zhou Y", "Wang M", "Wang C", "Zhu W", "Han Z", "Sun N", "Wang D"], "date": "2022-03-01T00:00:00Z", "doi": "10.4196/kjpp.2022.26.2.95", "meta_date_publication": "2022 Mar 1", "meta_volume": "26", "meta_issue": "2", "meta_pages": "95-111", "score": 50254.297, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @DISEASE_Pulmonary_Disease_Chronic_Obstructive @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@ and cigarette smoke extract-induced @<m>DISEASE_Glucocorticoid_Receptor_Deficiency</m> @DISEASE_MESH:C564221 @@@glucocorticoid resistance@@@ by activating the @GENE_NFE2L2 @GENE_4780 @@@nuclear factor E2-related factor 2@@@/@GENE_HMOX1 @GENE_24451 @@@heme oxygenase-1@@@ signaling pathway", "citations": {"NLM": "Tao F, Zhou Y, Wang M, Wang C, Zhu W, Han Z, Sun N, Wang D. Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway Korean J Physiol Pharmacol. 2022 Mar 1;26(2):95-111. PMID: 35203060", "BibTeX": "@article{35203060, title={Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway}, author={Tao F and Zhou Y and Wang M and Wang C and Zhu W and Han Z and Sun N and Wang D}, journal={Korean J Physiol Pharmacol}, volume={26}, number={2}, pages={95-111}}"}}, {"_id": "14557446", "pmid": 14557446, "title": "Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.", "journal": "J Clin Endocrinol Metab", "authors": ["Ibáñez L", "De Zegher F"], "date": "2003-10-01T00:00:00Z", "doi": "10.1210/jc.2003-030117", "meta_date_publication": "2003 Oct", "meta_volume": "88", "meta_issue": "10", "meta_pages": "4720-4", "score": 50054.973, "text_hl": "In OC+ @SPECIES_9606 @@@women@@@, the addition of @CHEMICAL_Flutamide @CHEMICAL_MESH:D005485 @@@flutamide@@@-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was associated with gain of lean mass and loss of total fat (P < 0.01 vs. ", "citations": {"NLM": "Ibáñez L, De Zegher F. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception. J Clin Endocrinol Metab. 2003 Oct;88(10):4720-4. PMID: 14557446", "BibTeX": "@article{14557446, title={Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.}, author={Ibáñez L and De Zegher F}, journal={J Clin Endocrinol Metab}, volume={88}, number={10}, pages={4720-4}}"}}]}